Research study Program year 2020 Source: CMS Open Payments

M15-862

ClinicalTrials.gov NCT02988960

Research payments

$1,591,218

192 payments

Through program year 2020, $1,591,218 in research payments was reported against M15-862, across 192 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT02988960

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$467,823	77
2019	Research	$1,123,396	115

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $1,591,218 192 payments

Who received the money Research payments · program years 2019–2020

Ut Md Anderson Cancer Center Teaching hospital · TX $526,185 15 payments
Cedars-Sinai Medical care Foundation Organisation paid for research $417,717 59 payments
Carolina Biooncology Institute Organisation paid for research $190,866 30 payments
Sarah Cannon Organisation paid for research $128,265 35 payments
Dana-Farber Cancer Institute Teaching hospital · MA $101,430 20 payments
University Of Chicago Hospitals Organisation paid for research $82,670 13 payments
Virginia Cancer Specialists Organisation paid for research $78,265 12 payments
Dcam Outpatient Pharmacy Organisation paid for research $63,071 6 payments
Michael Gibson Medical Oncology · Nashville, TN $2,750 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.